Safety of device implantation under antipatelet therapy with ticagrelor: About 20 cases.

Amara, W; Naccache, S; Akret, C; Cheggour, S; M'Zoughi, S; Galuscan, G; Dompnier, A

Amara, W; Naccache, S; Akret, C; Cheggour, S; M'Zoughi, S; Galuscan, G; Dompnier, A.

Afiliação

Amara W; Cardiologie, CHI, 93370 Le Rancy-Montfermeil, France. Electronic address: walamara@gmail.com.
Naccache S; Cardiologie, CHI, 93370 Le Rancy-Montfermeil, France.
Akret C; Cardiologie, centre hospitalier, 74000 Annecy, France.
Cheggour S; Cardiologie, centre hospitalier, 84000 Avignon, France.
M'Zoughi S; Cardiologie, centre hospitalier, 84000 Avignon, France.
Galuscan G; Cardiologie, centre hospitalier, 78000 Versailles, France.
Dompnier A; Cardiologie, centre hospitalier, 74000 Annecy, France.

Ann Cardiol Angeiol (Paris) ; 65(5): 378, 2016 Nov.

Article em En | MEDLINE | ID: mdl-27968767

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google